← Eichor
Study identifier: NCT05586984 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Transvaginal Sacrospinous Hysteropexy Versus Laparoscopic Uterine Lateral Suspension

Condition: Pelvic Organ Prolapse · Uterine Prolapse  ·  Sponsor: National Cheng-Kung University Hospital

PhaseN/A
Planned participants90
Who can joinFemale, 21 Years to no upper limit
Healthy volunteersNo

About this study

Transvaginal or transabdominal surgeries are current choices of uterus-preserving surgeries for pelvic organ prolapse. Laparoscopic lateral uterine suspension, a modified surgical approach of uterine suspension from bilateral abdominal wall fascia, performed with expected safety and simplicity of surgery besides advantages including small wound incision and fast recovery in laparoscopic surgeries. This trial aim to discuss the therapeutic efficacy, long term safety, and adverse events of laparoscopic lateral uterine suspension and compare with the conventional transvaginal sacrospinous ligament fixation with native tissue repair.

This description comes directly from the study's public registry record.

Talk to the study team

Yu Fang Huang, MD  ·  886-6-2353535  ·  yufangh@ncku.edu.tw

Always discuss trial participation with your own doctor first.

Locations (1)

National Cheng Kung University HospitalTainan, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05586984